0000014272-15-000048.txt : 20150210 0000014272-15-000048.hdr.sgml : 20150210 20150210181102 ACCESSION NUMBER: 0000014272-15-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150206 FILED AS OF DATE: 20150210 DATE AS OF CHANGE: 20150210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moed Samuel J CENTRAL INDEX KEY: 0001561017 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 15595424 MAIL ADDRESS: STREET 1: BRISTOL-MYERS SQUIBB COMPANY STREET 2: ROUTE 206 & PROVINCELINE ROAD CITY: LAWRENCEVILLE STATE: NJ ZIP: 08543 4 1 wf-form4_142360985199080.xml FORM 4 X0306 4 2015-02-06 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001561017 Moed Samuel J BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 1 0 0 SVP, Strat Plan & Analysis Common Stock, $0.10 par value 2015-02-06 4 M 0 27938 22.14 A 59838.464 D Common Stock, $0.10 par value 2015-02-06 4 S 0 21478 60.154 D 38360.464 D Option (right to buy) 22.14 2015-02-06 4 M 0 27938 0 D 2018-03-03 Common Stock, $0.10 par value 27938.0 0 D A portion of these shares were sold to cover exercise price and taxes in accordance with broker's procedure for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $60.08 to $60.185, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. All of the shares are currently exercisable. /s/ Robert J. Wollin, attorney-in-fact for Samuel J. Moed 2015-02-10